Combination treatment of CD38-expressing tumors
US9040050B2 · kind B2 · utility
28Cited by
5References
68Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2007 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Sep 25, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel method for the treatment of cancer using a combination therapy comprising an antibody that binds CD38, a corticosteroid and a non-corticosteroid chemotherapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.